Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Juan Pablo Gambini"'
Autor:
Doménica Tarallo, Jennyfer Martínez, Alejandro Leyva, Amy Mónaco, Carolina Perroni, Marcos Tassano, Juan Pablo Gambini, Mónica Cappetta, Rosario Durán, María Moreno, Celia Quijano
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-19 (2024)
Abstract Cellular senescence is a therapy endpoint in melanoma, and the senescence-associated secretory phenotype (SASP) can affect tumor growth and microenvironment, influencing treatment outcomes. Metabolic interventions can modulate the SASP, and
Externí odkaz:
https://doaj.org/article/8fd69163ea73458c852c04b1cde7b6ad
Autor:
María Emilia Tejería, María Pía Pereira, Juan Pablo Gambini, Pablo Duarte, Javier Gabriel Giglio, Ana María Rey
Publikováno v:
Pharmaceuticals, Vol 17, Iss 3, p 388 (2024)
“Click reactions” are a very useful tool for the selective conjugation of different molecular subunits to produce complex structures in a simple way. In this paper, we present the application of Cu(I)-catalyzed biorthogonal reactions between alky
Externí odkaz:
https://doaj.org/article/961bfd9a93d04b7c837f6a7508ab794e
Publikováno v:
Cirugía Plástica Ibero-Latinoamericana, Vol 44, Iss 3, Pp 303-309
Resumen Introducción y Objetivo La indocianina verde (ICG) es un colorante que se emplea junto con cámaras de infrarrojo cercano (NIR) portátiles para la evaluación de la perfusión tisular. El propósito del presente estudio es dar a conocer el
Externí odkaz:
https://doaj.org/article/764afdef42124fc5a87d4f6897d963cf
Autor:
María Pía Pereira, María Emilia Tejería, Maia Zeni, Juan Pablo Gambini, Pablo Duarte, Ana Rey, Javier Giglio
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 65:292-297
Autor:
Ana Jimenez-Pastor, Rafael Lopez-Gonzalez, Belén Fos-Guarinos, Fabio Garcia-Castro, Mark Wittenberg, Asunción Torregrosa-Andrés, Luis Marti-Bonmati, Margarita Garcia-Fontes, Pablo Duarte, Juan Pablo Gambini, Leonardo Kayat Bittencourt, Felipe Campos Kitamura, Vasantha Kumar Venugopal, Vidur Mahajan, Pablo Ros, Emilio Soria-Olivas, Angel Alberich-Bayarri
Publikováno v:
European Radiology.
Autor:
Juan Pablo Gambini, Mara de Souza Junqueira, Ximena Camacho, Pablo Cabral, Carlos Alberto Buchpiguel, Camila Maria Longo Machado, Natalia Oddone, Marcelo Fernández, Juan Claudio Benech, Hugo Cerecetto, Camila de Godoi Carneiro, María Fernanda García, Carolina Perroni, Daniele de Paula Faria, Eloisa Riva, Roger Chammas
Publikováno v:
Anti-Cancer Agents in Medicinal Chemistry. 21:1883-1893
Background: Multiple Myeloma (MM) is a malignant hematologic disorder and the second most common blood cancer. Interleukin-6 (IL-6) has been identified as a crucial factor for the proliferation and survival of MM cells and the overexpression of IL-6
Autor:
Gabriel Adrián González, Eduardo Savio, Liliana Servente, Juan Pablo Gambini, Henry Engler, Omar Alonso, Enrique Gustavo Cuña
Publikováno v:
World Journal of Nuclear Medicine, Vol 18, Iss 3, Pp 251-257 (2019)
COLIBRI
Universidad de la República
instacron:Universidad de la República
COLIBRI
Universidad de la República
instacron:Universidad de la República
The aim of this study was quantitative comparison between 68Ga-Gallgas positron emission tomography (PET) and 99mTc-Technegas single photon emission computed tomography (SPECT) for lung ventilation function assessment in patients with moderate-to-sev
Autor:
Guang-Zhong Yang, Pablo Cabral, Juan Hermida, Santiago Matalonga, Omar Alonso, Ricardo Vila, Juan Pablo Gambini, Thomas P. Quinn
Publikováno v:
Molecular Imaging and Biology. 20:1-584
Autor:
Williams Porcal, Mirel Cabrera, Pablo Cabral, Marcelo Fernández, Nicole Lecot, Juan Pablo Gambini
Publikováno v:
AAPS PharmSciTech. 22
Nanomedicine is a highly demanded discipline. Liposomes have seen an increased attention due to their physicochemical properties that allow them to act as nanocarriers of drugs and also of radioisotopes that can be used to diagnose and treat cancer.
Autor:
María Fernanda García, Ximena Camacho, Juan Pablo Gambini, Eloisa Riva, Carolina Rosal, Roger Chammas, Daniela B Zanatta, Camila Maria Longo Machado, Natalia Oddone, Agustina Banchero, Pablo Cabral, Marcelo Fernández, Carlos Alberto Buchpiguel
Publikováno v:
Oncology. 92:229-242
Introduction: Rituximab was the first monoclonal antibody approved for the treatment of B-cell non-Hodgkin lymphoma (NHL) expressing CD20 antigen. This antibody has also the potential to be used as a specific fluorescent and radiolabel agent for targ